Evidence map›Paper›PMID 32304215›Full record

ReviewInternational immunology2020

Hide and seek: interplay between influenza viruses and B cells.

Masayuki Kuraoka, Yu Adachi, Yoshimasa Takahashi

Open access · bronzeAbstract readReview
In one paragraph

Review in International immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Subdominance in Antibody Responses: Implications for Vaccine Development.Microbiology and molecular biology reviews : MMBR · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Masayuki KuraokaDepartment of Immunology, Duke University, Durham, NC, USA.
Yu AdachiDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Yoshimasa TakahashiDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
National Institute of Infectious Diseases · JPDuke University · US

Funding

Virology CoreP01AI089618 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI STEPHEN COPLAN HARRISON · 2011 to 2026
$40.0M
Structures and Interactions of Antibodies Produced by Affinity MaturationU19AI117892 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HARRISON, STEPHEN COPLAN · 2015 to 2019
$9.2M
Immunity to novel T/F SHIVs: variability in the co-evolution of virus and host immunityR01AI128832 · NIAID · DUKE UNIVERSITY · PI KELSOE, GARNETT H · 2017 to 2021
$5.4M
NIAID NIH HHS P01 AI089618NIAID NIH HHS R01 AI128832NIAID NIH HHS U19 AI117892
6 · The paper itself

Abstract

Influenza virus constantly acquires genetic mutations/reassortment in the major surface protein, hemagglutinin (HA), resulting in the generation of strains with antigenic variations. There are, however, HA epitopes that are conserved across influenza viruses and are targeted by broadly protective antibodies. A goal for the next-generation influenza vaccines is to stimulate B-cell responses against such conserved epitopes in order to provide broad protection against divergent influenza viruses. Broadly protective B cells, however, are not easily activated by HA antigens with native structure, because the virus has multiple strategies to escape from the humoral immune responses directed to the conserved epitopes. One such strategy is to hide the conserved epitopes from the B-cell surveillance by steric hindrance. Technical advancement in the analysis of the human B-cell antigen receptor (BCR) repertoire has dissected the BCRs to HA epitopes that are hidden in the native structure but are targeted by broadly protective antibodies. We describe here the characterization and function of broadly protective antibodies and strategies that enable B cells to seek these hidden epitopes, with potential implications for the development of universal influenza vaccines.

Indexed as

B-LymphocytesHemagglutininsHumansOrthomyxoviridaeReceptors, Antigen, B-CellHemagglutininsReceptors, Antigen, B-CellB-cell responsesbroadly protective antibodiesgerminal centersoccluded epitope

Identifiers

PMID32304215
PMCPMC7478158
OpenAlexW3017312411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.